Studies related to Liver Enzymes and Saffron

The Effect Of Saffron ( Crocus Sativus L.) Supplementation On Blood Pressure, And Renal And Liver Function In Patients With Type 2 Diabetes Mellitus: A Double-blinded, Randomized Clinical Trial

Effect None
Values U/L. AST. Placebo: before 22.1±8.5, after 19.8±7.5. Saffron: before 22.4±10.3, after 21.2±8.8. ALT Placebo: before 23.6±11.1, after 20.8±11 Saffron: before 22.35±10.7, after. ALP Placebo: before 167.1±46.6, after 166.4±45.2. Saffron: before 177.1±49.6, after 172.3±45.8.
Trial Design Randomized trial
Trial Length 1-6 months
Number of Subjects 80
Sex Both Genders
Age Range 30-44, 45-64, 65+
Notes for this study:
In a randomized, double-blind, placebo-controlled trial, 80 participants with type 2 diabetes took 100 mg of saffron powder or placebo for 12 weeks.

There wasn't an effect on liver enzymes, creatinine, urea, or albumin. There was a reduction in systolic blood pressure but not diastolic.

The trial was preregistered: IRCT201510259472N9

Full details on all 7 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.